Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Payables (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Payables for 4 consecutive years, with $3.8 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables fell 17.17% year-over-year to $3.8 billion, compared with a TTM value of $3.8 billion through Dec 2025, down 17.17%, and an annual FY2025 reading of $3.8 billion, down 17.17% over the prior year.
  • Payables was $3.8 billion for Q4 2025 at GE HealthCare Technologies, down from $5.0 billion in the prior quarter.
  • Across five years, Payables topped out at $5.2 billion in Q1 2025 and bottomed at $2.8 billion in Q3 2023.
  • Average Payables over 4 years is $3.9 billion, with a median of $3.9 billion recorded in 2024.
  • The sharpest move saw Payables soared 40.88% in 2024, then dropped 17.17% in 2025.
  • Year by year, Payables stood at $3.0 billion in 2022, then skyrocketed by 33.59% to $4.0 billion in 2023, then increased by 14.77% to $4.5 billion in 2024, then decreased by 17.17% to $3.8 billion in 2025.
  • Business Quant data shows Payables for GEHC at $3.8 billion in Q4 2025, $5.0 billion in Q3 2025, and $5.0 billion in Q2 2025.